Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Overview of glucagon-like peptide-1 and its role in glucose metabolism New-generation antidiabetic agents, particularly those targeting the glucagon-like peptide-1 (GLP-1) pathway, represent a significant advancement in the treatment of type 2 diabetes
Poor blood sugar management increases the risk of both acute complications (such as hyperglycemia) and long-term microvascular and macrovascular complications
15% of US consumers are now using GLP-1s for weight management - roughly 3 million people - and 45% are either using, have used, or are interested
WHO also reports that in 2022, 890 million adults were living with obesity and 43% of adults worldwide were overweight
US$ 28.86
US$ 28.89
US$ 29.34
